Author

Laurence Hermitte

Observed names: HERMITTE, Laurence, Hermitte, Laurence, L Hermitte, L. Hermitte

Observed institutions: Aix-Marseille Université, Hôpital Sainte-Marguerite, Hôpital de la Timone

OpenAlex ID: A5020808065

Paradoxical lessening of autoimmune processes in non‐obese diabetic mice afterinfection with the diabetogenic variant of encephalomyocarditis virus

1990 · Laurence Hermitte, Bernard Vialettes, et al. · European Journal of Immunology · 54

Autoimmune polyendocrine failure — Type 1 (insulin-dependent) diabetes mellitus and hypothyroidism — after allogenic bone marrow transplantation in a patient with lymphoblastic leukaemia

1993 · B. Vialettes, D. Maraninchi, et al. · Diabetologia · 52

Diverging evolution of anti-GAD and anti-IA-2 antibodies in long-standing diabetes mellitus as a function of age at onset: no association with complications

1998 · L. Hermitte, C. Atlan-Gepner, et al. · Diabetic Medicine · 29

High Dose Nicotinamide Fails to Prevent Diabetes in BB Rats

1989 · L. Hermitte, B. Vialettes, et al. · Autoimmunity · 22

Non-clinical assessment of lubrication and free radical scavenging of an innovative non-animal carboxymethyl chitosan biomaterial for viscosupplementation: An in-vitro and ex-vivo study

2021 · Jean-Michel Vandeweerd, Bernado Innocenti, et al. · PLoS ONE · 16

Humoral Immunity Against Glutamic Acid Decarboxylase and Tyrosine Phosphatase IA-2 in Lambert–Eaton Myasthenic Syndrome

2000 · Laurence Hermitte, Nicole Martin-Moutot, et al. · Journal of Clinical Immunology · 14

First-in-human Study to Evaluate a Single Injection of KiOmedine®CM-Chitosan for Treating Symptomatic Knee Osteoarthritis

2022 · P.J. Emans, G. Skaliczki, et al. · The Open Rheumatology Journal · 12

Dietary protection against diabetes in NOD mice: lack of a major change in the immune system.

1995 · L Hermitte, C Atlan-Gepner, et al. · PubMed · 12

Biological Safety Evaluation of KiOmedine® CM-chitosan, an Innovative Non-animal Carboxymethyl-Chitosan Biomaterial Intended for Injectable Biomedical Applications

2020 · Pierre Douette, Mickael Chausson, et al. · Journal of Biomaterials · 9

The Soluble Receptor of Interleukin 2 is Not a Serum Marker of the Autoimmune Activity in Type I Diabetes Mellitus

1991 · B. Vialettes, N. Schmitt, et al. · Autoimmunity · 6

Different TH2-TH1 balance in V beta 8 and V beta 6 subsets of splenocytes in NOD females in the early phase of diabetogenesis.

1997 · C Atlan-Gepner, L Hermitte, et al. · PubMed · 3

Safety and efficacy of a carboxymethyl chitosan dermal injection device for the treatment of skin defects: a first-in-man, pilot, comparative, split-body study

2021 · Catherine Philippart, Benoit Hendrickx, et al. · European Journal of Dermatology · 2

Specific immunotherapy for the prevention of diabetes: Theoretical and practical aspects

1993 · B. Vialettes, C. Atlan‐Gepner, et al. · Diabetes/Metabolism Reviews · 1

Corrélation des propriétés physico-chimiques de biopolymères à la réponse cellulaire : Contribution à l'élaboration de nouveaux implants anti-cataracte secondaire

2002 · Laurence Hermitte

Works count: 16

Citation count: 232

H-index: 9

I10-index: 8